Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-02

Clinical Trial Update: The Lilac Device Trial [NA]

View source ↗

Summary

A clinical trial update indicates that the Lilac Device trial by Luminate Medical is currently recruiting for chemotherapy-induced peripheral neuropathy (CIPN).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lilac Device

Snippet

Sponsor: Luminate Medical, Inc. | Conditions: Chemotherapy Induced Peripheral Neuropathy (CIPN) | NA | Status: RECRUITING